Use of an antibody-ricin A-chain conjugate to delete neoplastic B cells from human bone marrow
- PMID: 6409188
Use of an antibody-ricin A-chain conjugate to delete neoplastic B cells from human bone marrow
Abstract
Affinity-purified rabbit antibody to human lambda and kappa chains (R alpha H lambda kappa) was conjugated to the A-chain of the plant toxin, ricin. The resulting immunotoxin (R alpha H lambda kappa-A) killed cells from the tumor cell line Daudi, which bears surface immunoglobulin, but was nontoxic to the CFU-E, BFU-E, and CFU-GM of human bone marrow. R alpha H lambda kappa-A eliminated 99% of clonogenic Daudi cells that had been mixed with marrow cells in vitro, without demonstrable toxicity to hematopoietic cells. Thus, in vitro treatment of marrow with R alpha H lambda kappa-A may increase the incidence of cure following autologous bone marrow transplantation for the treatment of human B-cell malignancies.
Similar articles
-
Effects of anti-CD33 blocked ricin immunotoxin on the capacity of CD34+ human marrow cells to establish in vitro hematopoiesis in long-term marrow cultures.Exp Hematol. 1992 May;20(4):442-8. Exp Hematol. 1992. PMID: 1373688
-
Autologous transplantation of bone marrow purged in vitro with anti-CD7-(WT1-) ricin A immunotoxin in T-cell lymphoblastic leukemia and lymphoma.Blood. 1989 Aug 15;74(3):1152-8. Blood. 1989. PMID: 2473811
-
Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.Cancer Res. 1986 Mar;46(3):1208-13. Cancer Res. 1986. PMID: 3510720
-
Evaluation of monoclonal antibody DF3 conjugated with ricin as a specific immunotoxin for in vitro purging of human bone marrow.Cancer Res. 1990 Feb 15;50(4):1170-5. Cancer Res. 1990. PMID: 2404589
-
Selective killing of normal or neoplastic B cells by antibodies coupled to the A chain of ricin.Proc Natl Acad Sci U S A. 1980 Sep;77(9):5419-23. doi: 10.1073/pnas.77.9.5419. Proc Natl Acad Sci U S A. 1980. PMID: 6968912 Free PMC article.
Cited by
-
Cytotoxicity of a cell-reactive immunotoxin containing ricin A chain is potentiated by an anti-immunotoxin containing ricin B chain.J Exp Med. 1984 Jul 1;160(1):341-6. doi: 10.1084/jem.160.1.341. J Exp Med. 1984. PMID: 6736871 Free PMC article.
-
Synergy of ricin A chain-containing immunotoxins and ricin B chain-containing immunotoxins in in vitro killing of neoplastic human B cells.Proc Natl Acad Sci U S A. 1983 Oct;80(20):6332-5. doi: 10.1073/pnas.80.20.6332. Proc Natl Acad Sci U S A. 1983. PMID: 6578512 Free PMC article.
-
Recent advances in the treatment of acute lymphoblastic leukemia in adults and future prospects.Trans Am Clin Climatol Assoc. 1985;96:41-55. Trans Am Clin Climatol Assoc. 1985. PMID: 6599218 Free PMC article. No abstract available.
-
Advances in the applications of monoclonal antibodies in clinical oncology. University of London Royal Postgraduate Medical School. 8th-10th May, 1985. Abstracts.Br J Cancer. 1985 Oct;52(4):641-68. doi: 10.1038/bjc.1985.240. Br J Cancer. 1985. PMID: 4063142 Free PMC article. No abstract available.
-
Peptides and proteins as drugs.Pharm Res. 1985 Jul;2(4):151-6. doi: 10.1023/A:1016327803573. Pharm Res. 1985. PMID: 24272804
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources